| VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
|---|---|---|---|---|---|---|---|---|
| TVIS30079080 | HIV | ENSG00000169836.5 | protein_coding | TACR3 | No | No | 6870 | P29371 |
| TVIS30060720 | HIV | ENSG00000169836.5 | protein_coding | TACR3 | No | No | 6870 | P29371 |
| TVIS20033534 | HPV | ENSG00000169836.5 | protein_coding | TACR3 | No | No | 6870 | P29371 |
| TVIS20058844 | HPV | ENSG00000169836.5 | protein_coding | TACR3 | No | No | 6870 | P29371 |
| TVIS20057902 | HPV | ENSG00000169836.5 | protein_coding | TACR3 | No | No | 6870 | P29371 |
| TVIS44008558 | HTLV-1 | ENSG00000169836.5 | protein_coding | TACR3 | No | No | 6870 | P29371 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
| Gene | TACR3 |
|---|---|
| DrugBank ID | DB15669 |
| Drug Name | Fezolinetant |
| Target ID | BE0002371 |
| UniProt ID | P29371 |
| Regulation Type | antagonist |
| PubMed IDs | 33724119 |
| Citations | Depypere H, Lademacher C, Siddiqui E, Fraser GL: Fezolinetant in the treatment of vasomotor symptoms associated with menopause. Expert Opin Investig Drugs. 2021 Jul;30(7):681-694. doi: 10.1080/13543784.2021.1893305. Epub 2021 Jul 12. |
| Groups | Approved; Investigational |
| Direct Classification | 4-halobenzoic acids and derivatives |
| SMILES | C[C@H]1N(CCN2C1=NN=C2C1=NC(C)=NS1)C(=O)C1=CC=C(F)C=C1 |
| Pathways | |
| PharmGKB | |
| ChEMBL | CHEMBL3608680 |
